Emerging research implicates neuroinflammatory pathways in the pathogenesis of PSD (Hu et al., 2019), where post-stroke immune activation mediates elevated cerebral cytokine production (IL-1β, IL-6, TNF-α). This evidence concerns the gene IL1B and stroke disorder.